Laborie Medical Technologies announced today that it completed the acquisition of drug-coated balloon developer Urotronic. The companies struck an agreement last month for Laborie to buy Urotronic for up to $600 million. Urotronic developed the Optilume DCB used in interventional urology procedures. It treats urethral strictures and benign prostatic hyperplasia (BPH) or enlarged prostate conditions. […]
Mergers & Acquisitions
iCad sells Xoft brachytherapy business to Elekta
iCad today announced it sold its Xoft Brachytherapy business line to Elekta for approximately $5.5 million. Elekta is taking over the business, effective immediately, and will make final payments to iCad no later than November 6, 2023. As part of the deal, Elekta will assume all liabilities, and employees will transfer with the business. The […]
Silony Medical completes acquisition of Centinel Spine’s global fusion business
Silony Medical this week completed the acquisition of Centinel Spine’s global fusion business. The acquisition adds to Silony Medical’s Verticale posterior screw and rod fusion platform, its Roccia and Favo Interbody Fusion (IBF) systems with Stalif technology. Through the acquisition, Silony will change its name to Silony Spine to underscore its commitment to focus on […]
Pixium Vision looks for a buyer
Pixium Vision this week said it launched a tender process for the purpose of finding buyers to acquire the company’s business. The company has been unable to find financial investors within the restricted timeframe and in line with Pixium Vision’s needs. Pixium Vision is requesting the conversion of safeguard proceedings into receivership. The deadline for […]
Henry Schein completes majority interest acquisition of Shield Healthcare
Henry Schein this week announced it completed the previously announced acquisition of majority interest in Shield Healthcare. The company announced the deal in August as officials saw the move as bolstering the company’s commitment to facilitating a continuum-of-care delivery model. Henry Schein expects the transaction to be neutral to 2023 non-GAAP earnings per share and […]
EU orders Illumina to divest Grail after ‘unlawful’ merger
The European Commission today announced it has ordered Illumina (Nasdaq: ILMN) — the DNA sequencing and array-based tech developer — to unwind and divest its Grail acquisition. The decision follows the commission’s decision to prohibit the transaction in September 2022 over concerns the merger would be anticompetitive and “stifle” innovation in the market. Despite the […]
Getinge makes infection prevention play with Healthmark buy
Getinge announced today that it has acquired Healthmark Industries, a Fraser, Michigan–based provider of instrument care and infection control consumables. The Swedish medtech company paid $320 million in cash for 100% of Healthmark. The acquisition aims to bolster Getinge’s footprint in the U.S. sterile reprocessing market while paving the way for Healthmark’s global expansion. The […]
Teleflex completes Palette Life Sciences acquisition
Teleflex (NYSE: TFX) this week completed the previously announced acquisition of Palette Life Sciences. The Wayne, Pennsylvania-based company first announced the acquisition in July. Under the terms of the agreement, Teleflex bought Palette for an upfront cash payment of $600 million at closing, with additional consideration of up to $50 million upon the achievement of […]
Novo Nordisk acquires all shares of drug delivery device maker Biocorp
Novo Nordisk today officially acquired 100% of the shares of Biocorp, the France-based drug delivery device maker’s CEO announced. Biocorp designs, develops and manufactures drug delivery systems and medical devices. Its offerings include Mallya, a Bluetooth-enabled smart add-on device for pen injectors. The Mallya smart sensor attaches directly to insulin pen injectors to make them […]
How Medtronic, Zimmer Biomet and Smith+Nephew approach medtech M&A
In a year with some massive acquisitions in medtech, there are still questions around an overall drop in M&A activity. According to Pete Cataldo, managing director and medtech head of Truist, deal volume in the sector fell 65% in the first half of 2023. However, despite high interest rates and a volatile stock market, there […]
Haemonetics to acquire OpSens for more than $250M, expanding cardiology device portfolio
Haemonetics today announced a definitive agreement to acquire cardiology-focused technology developer OpSens. Boston-based Haemonetics will acquire all outstanding shares of Opsens for CAD $2.90 in an all-cash transaction that will have a fully diluted equity value of approximately $253 million USD. The transaction is expected to close by the end of January 2024. Opsens develops […]